2 articles · Updated · The Washington Post · May 2
She died on 21 April at Inova Fairfax Hospital in Virginia, six years after a Stage 4 diagnosis and an initial prognosis of six months.
Sayas served in the Biden White House on the Cancer Moonshot and helped create a congressional Colorectal Cancer Caucus while advocating for earlier screening and more research funding.
Her death comes as colorectal cancer rises among younger people; the American Cancer Society says it is now the deadliest cancer for patients under 50.
How can the cancer community ensure Asal Sayas’s legacy leads to lasting improvements in young-onset colorectal cancer detection and care for underserved groups?
As colorectal cancer rises in younger adults, what new strategies could help overcome barriers to early screening and diagnosis?
With federal funding cuts disrupting cancer trials, what innovative solutions could close the gap in research and access for at-risk populations?
Young-Onset Colorectal Cancer Surges as Leading Cause of Death Under 50: The Impact and Legacy of Advocate Asal Sayas
Overview
Asal Sayas, a passionate advocate who battled young-onset colorectal cancer for six years, passed away in April 2026. Her diagnosis sparked a powerful advocacy career, including roles as a senior White House advisor and leader at the Colorectal Cancer Alliance, where she pushed for increased research funding, early detection awareness, and support services tailored to young adults. Colorectal cancer rates are rising sharply among people under 50, leading to lowered screening ages and increased diagnoses. Despite progress, challenges like delayed diagnosis, financial hardship, and legislative hurdles remain. Sayas's legacy continues to inspire intensified efforts in research, awareness, and policy to combat this growing epidemic.